• Home
  • Textbooks
  • Pharmacology
  • Drugs for Hyperlipidemia

Pharmacology

George M. Brenner, Craig W. Stevens

Chapter 15

Drugs for Hyperlipidemia - all with Video Answers

Educators


Chapter Questions

01:45

Problem 1

An otherwise healthy 58-year-old man is found to have an LDL-C level of $170 \mathrm{mg} / \mathrm{dL}$, an HDL-C level of $50 \mathrm{mg} / \mathrm{dL}$, and a triglyceride level of $105 \mathrm{mg} / \mathrm{dL}$. He has no other risk factors for CHD. In addition to TLCs, which drug treatment is most appropriate for this patient?
(A) cholestyramine
(B) simvastatin
(C) niacin
(D) ezetimibe
(E) gemfibrozil

Anthony Han
Anthony Han
Numerade Educator
01:01

Problem 2

A man with hyperlipidemia is treated with an agent that increases expression of lipoprotein lipase. Which of the following effects would be most likely result from this action?
(A) increased LDL-C levels
(B) decreased HDL-C levels
(C) increased serum triglyceride levels
(D) decreased serum triglyceride levels
(E) decreased LDL-C levels

Narayan Hari
Narayan Hari
Numerade Educator

Problem 3

A woman experiences flushing and pruritus over her upper body after starting a drug for hyperlipidemia. Which mechanism is responsible for the effect of this drug on hepatic triglyceride synthesis?
(A) activation of the PPAR- $\alpha$
(B) disruption of the annexin-caveolin complex
(C) binding to a $\mathrm{G}$ protein-coupled receptor
(D) inhibition of $\mathrm{HMG}-\mathrm{CoA}_{\mathrm{A}}$ reductase
(E) binding to deoxycholic acid

Check back soon!
01:10

Problem 4

A man is placed on a drug that disrupts annexin and caveolin. Which effect results from this action?
(A) decreased cholesterol synthesis
(B) decreased triglyceride synthesis
(C) decreased cholesterol absorption
(D) decreased triglyceride absorption
(E) increased bile acid excretion

Hast Aggarwal
Hast Aggarwal
Numerade Educator